Younong Yu
Publications by Year
Research Areas
Chemokine receptors and signaling, Chemical Synthesis and Analysis, Synthesis and biological activity, Chronic Lymphocytic Leukemia Research, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation(2018)136 cited
- → Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist(2006)113 cited
- → Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents(2003)92 cited
- → Identification of Oxidation Products of (−)-Epigallocatechin Gallate and (−)-Epigallocatechin with H2O2(2000)58 cited
- → Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group(2020)53 cited
- → Synthesis of the Oxygenated Pactamycin Core(2007)45 cited
- → C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists(2007)43 cited
- → Discovery of 8-Amino-imidazo[1,5-a]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis(2015)38 cited
- → Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance(2020)27 cited
- → Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation(2020)26 cited